TOP-1288
- Generic Name
- TOP-1288
- Drug Type
- Small Molecule
- Chemical Formula
- C43H49N7O9S
- CAS Number
- 1630202-02-6
- Unique Ingredient Identifier
- 19ZTZ9YC4O
- Background
TOP-1288 is under investigation in clinical trial NCT02888379 (Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis).
Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects
- First Posted Date
- 2017-03-06
- Last Posted Date
- 2018-09-20
- Lead Sponsor
- Topivert Pharma Ltd
- Target Recruit Count
- 37
- Registration Number
- NCT03071081
- Locations
- 🇬🇧
PAREXEL Early Phase Clinical Unit, London, United Kingdom
Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis
- First Posted Date
- 2016-09-05
- Last Posted Date
- 2017-07-07
- Lead Sponsor
- Topivert Pharma Ltd
- Target Recruit Count
- 77
- Registration Number
- NCT02888379
Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2017-05-23
- Lead Sponsor
- Topivert Pharma Ltd
- Target Recruit Count
- 67
- Registration Number
- NCT02463045
- Locations
- 🇬🇧
CTU, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath